Obexelimab for the Treatment of IgG4-Related Disease.

Della-Torre E, Baker MC, Zhang W, Perugino CA, Katz G, Tanaka Y, Khosroshahi A, Kleger A, Schleinitz N, Martinez-Valle F, Schulze-Koops H, Nakayamada S, Rebours V, Okazaki K, Dong L, Carruthers M, Chen LYC, Frulloni L, Meysami A, Takahashi H, Kawano M, Liu Y, Saeki T, Ebbo M, Alexander T, González García A, Karadag O, Maślińska M, Quinn SM, Poma A, Wells A, Greene TJ, Stone JH, Culver EL, INDIGO Trial Investigators

Open source

DOI: 10.1056/nejmoa2601337
Published: 2026 Jun 2
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2601337,
  title = {Obexelimab for the Treatment of IgG4-Related Disease.},
  author = {Della-Torre E and Baker MC and Zhang W and Perugino CA and Katz G and Tanaka Y and Khosroshahi A and Kleger A and Schleinitz N and Martinez-Valle F and Schulze-Koops H and Nakayamada S and Rebours V and Okazaki K and Dong L and Carruthers M and Chen LYC and Frulloni L and Meysami A and Takahashi H and Kawano M and Liu Y and Saeki T and Ebbo M and Alexander T and González García A and Karadag O and Maślińska M and Quinn SM and Poma A and Wells A and Greene TJ and Stone JH and Culver EL and INDIGO Trial Investigators},
  year = {2026},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2601337},
  url = {https://doi.org/10.1056/nejmoa2601337}
}

RIS

TY  - JOUR
TI  - Obexelimab for the Treatment of IgG4-Related Disease.
AU  - Della-Torre E
AU  - Baker MC
AU  - Zhang W
AU  - Perugino CA
AU  - Katz G
AU  - Tanaka Y
AU  - Khosroshahi A
AU  - Kleger A
AU  - Schleinitz N
AU  - Martinez-Valle F
AU  - Schulze-Koops H
AU  - Nakayamada S
AU  - Rebours V
AU  - Okazaki K
AU  - Dong L
AU  - Carruthers M
AU  - Chen LYC
AU  - Frulloni L
AU  - Meysami A
AU  - Takahashi H
AU  - Kawano M
AU  - Liu Y
AU  - Saeki T
AU  - Ebbo M
AU  - Alexander T
AU  - González García A
AU  - Karadag O
AU  - Maślińska M
AU  - Quinn SM
AU  - Poma A
AU  - Wells A
AU  - Greene TJ
AU  - Stone JH
AU  - Culver EL
AU  - INDIGO Trial Investigators
PY  - 2026
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2601337
UR  - https://doi.org/10.1056/nejmoa2601337
ER  -

APA

E, D., MC, B., W, Z., CA, P., G, K., Y, T., A, K., A, K., N, S., F, M., H, S., S, N., V, R., K, O., L, D., M, C., LYC, C., L, F., A, M., H, T., M, K., Y, L., T, S., M, E., T, A., A, G. G., O, K., M, M., SM, Q., A, P., A, W., TJ, G., JH, S., EL, C., & Investigators, I. T. (2026). Obexelimab for the Treatment of IgG4-Related Disease.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2601337

Source records

pubmed · retrieved 2026-09-26T02:07:18.997Z